Glucagon-like peptide 1 agonists and death from any cause in primary care setting

Nirantharakumar, K.; Willis, B. H.; Marshall, T.; Kumarendran, B.; Ghosh, S.; Narendran, P.; Thomas, G. N.; Ponnusamy, S.; Hanif, W.; Toulis, K. A.; Cheng, K.; Gokhale, K.

Author

Nirantharakumar, K.
Willis, B. H.
Marshall, T.
Kumarendran, B.
Ghosh, S.
Narendran, P.
Thomas, G. N.
Ponnusamy, S.
Hanif, W.
Toulis, K. A.

Show all

Affiliation

University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; George Eliot Hospital, Nuneaton

Publication date

2017-03-08

Subject

Diabetes

Metadata

Show full item record

Abstract

Poster abstract P417 from the section Clinical care and other categories posters: new technology, therapies and treatment, Diabetes UK Professional Conference 2017, Manchester Central, Manchester, 8–10 March 2017.

Citation

Nirantharakumar K, Willis BH, Marshall T, Kumarendran B, Ghosh S, Narendran P, Thomas GN, Ponnusamy S, Hanif W, Toulis KA, Cheng K, Gokhale K. Glucagon-like peptide 1 agonists and death from any cause in primary care setting. Diabetic Medicine. 2017 Mar;34(S1):159. doi: 10.1111/dme.37_13304.

Type

Conference Output